Publications by authors named "Katherine Ruffner"

Claim this Profile
S
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.
Yael P Mossé, Megan S Lim, Stephan D Voss, Keith Wilner, Katherine Ruffner

Lancet Oncol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.
D Ross Camidge, Yung-Jue Bang, Eunice L Kwak, A John Iafrate, Marileila Varella-Garcia, Katherine Ruffner

Lancet Oncol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria.
Madan Jagasia, Jennifer Giglia, Wichai Chinratanalab, Sheri Dixon, Heidi Chen, Katherine Ruffner

Biol Blood Marrow Transplant· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes.
Brian G Engelhardt, Derek W Holland, Stephen J Brandt, Wichai Chinratanalab, Stacey A Goodman, Katherine L Ruffner

Leuk Lymphoma· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission.
John M Pagel, Frederick R Appelbaum, Janet F Eary, Joseph Rajendran, Darrell R Fisher, Katherine Ruffner

Blood· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted radiotherapy as an adjunct to hematopoietic stem cell transplantation for advanced leukemia.
Katherine L Ruffner

Cancer Biother Radiopharm· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis